Company intelligence / Profile preview

Precision Analytical

Ownership: Private
Employees: ~99
Development stage: Commercial

Overview

Precision Analytical has commercialized the DUTCH Test—a dried urine-based hormone testing methodology—used globally by thousands of healthcare providers. The company’s tests are validated in peer-reviewed studies and are CLIA-certified. Over eleven million metabolite tests have been performed to date. The clinical utility of their tests includes improved diagnosis and management of complex hormonal conditions.

Therapeutic areas: PsychiatryEndocrinologyWomen's Health
Modalities: Diagnostic test (Dried urine hormone analysis)Laboratory-developed test (LDT)Non-pharmacological therapy (diagnostic only; not a therapeutic developer)
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Precision Analytical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Precision Analytical.

Explore the full profile